Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: a systematic review

M McPherson, S Economidou, A Liampas, P Zis… - Seminars in Arthritis and …, 2022 - Elsevier
Introduction Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive
clinically amyopathic dermatomyositis (CADM) is frequently associated with rapidly …

[PDF][PDF] Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection

JR Hannah, SS Ali, D Nagra, MA Adas… - Clin Exp …, 2022 - clinexprheumatol.org
Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in
SARS-CoV-2 infection Page 1 Clinical and Experimental Rheumatology 2022 Clinical and …

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

MT Holzer, M Krusche, N Ruffer, H Haberstock… - Rheumatology …, 2022 - Springer
Dermatomyositis is a rare, type I interferon-driven autoimmune disease, which can affect
muscle, skin and internal organs (especially the pulmonary system). In 2021, we have noted …

Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review

D Gonzalez, L Gupta, V Murthy, EB Gonzalez… - Rheumatology …, 2022 - Springer
Abstract Anti-MDA5 (Melanoma differentiation-associated protein 5) myositis is a rare
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …

Epidemiology of the idiopathic inflammatory myopathies

T Khoo, JB Lilleker, BYH Thong, V Leclair… - Nature Reviews …, 2023 - nature.com
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …

COVID-19 disease and dermatomyositis: a mini-review

J Qian, H Xu - Frontiers in immunology, 2022 - frontiersin.org
The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has
caused a large number of deaths, and there is still no effective treatment. COVID-19 can …

[HTML][HTML] New-onset dermatomyositis following COVID-19: A case report

H Shimizu, H Matsumoto, T Sasajima, T Suzuki… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Most of the infected individuals have …

Anti-MDA5 antibody linking COVID-19, type I interferon, and autoimmunity: a case report and systematic literature review

A Tonutti, F Motta, A Ceribelli, N Isailovic… - Frontiers in …, 2022 - frontiersin.org
Introduction The SARS-CoV-2 infection has been advocated as an environmental trigger for
autoimmune diseases, and a paradigmatic example comes from similarities between COVID …

[HTML][HTML] Management of interstitial lung disease (ILD) in myositis syndromes: a practical guide for clinicians

P Mehta, R Aggarwal, JC Porter… - Best Practice & Research …, 2022 - Elsevier
Inflammatory myopathies are heterogeneous clinico-serological syndromes, with variable
clinical manifestations. Interstitial lung disease (ILD) is a major cause of morbidity and …

Anti-MDA5 dermatomyositis: an update from bench to bedside

E Fuzzi, M Gatto, M Zen, C Franco… - Current Opinion in …, 2022 - journals.lww.com
Anti-MDA5+ dermatomyositis has a wider spectrum of manifestations than previously
thought. A high index of suspicion is needed not to miss atypical presentations. In the setting …